Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1405864

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1405864

Overactive Bladder Treatment Market Size, Share & Trends Analysis Report, By Type (Anticholinergics, Mirabegron, Neuromodulation, Botox), By Disease Type (Idiopathic, Neurogenic), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Overactive Bladder Treatment Market Growth & Trends:

The global overactive bladder treatment market size is expected to reach USD 5.25 billion by 2030, and is estimated to register a CAGR of 4.8% over the forecast period, according to a new report by Grand View Research, Inc. Factors such as the growing awareness about the overactive bladder (OAB) condition, along with rising R&D investments to develop novel formulations for this disease, are projected to drive the global market. In addition, rising competition owing to high demand for OAB medications and treatments and rising emphasis of major players to manufacture drugs is another vital factor propelling the demand forward.

Rising awareness about OAB and urinary incontinence among the population is one of the major factors bolstering the growth of the market. Various key players operating in the industry undertake numerous initiatives to raise awareness about the overactive bladder condition. For instance, in January 2023, Urovant Sciences, a key player operating in the market, collaborated with actress and patient Holly Robinson Peete under a campaign to bring awareness to OAB. Such initiatives help increase awareness and knowledge about the treatment options thereby increasing treatment adoption.

Moreover, increasing investments to develop innovative formulations and treatments targeting OAB are anticipated to fuel growth over the forecast period. For instance, in November 2019, EBT Medical, Inc., a startup, received funding of USD 10 million in series A for developing noninvasive neuromodulation technology to treat overactive bladder. Thus, developments and investments focusing on medications and treatments are anticipated to fuel the geographic expansion.

Furthermore, industry participants are undertaking various strategies like collaborations and new product launches to maintain their position in this competitive market. For instance, in March 2023, KYORIN Pharmaceutical Co., Ltd. collaborated with Sumitomo Pharma Co., Ltd. to develop, manufacture, and commercialize Vibegron for OAB in Taiwan and other Asian Countries like Singapore, Hong Kong, Indonesia, and Vietnam. Such collaborations among major players are expected to increase the accessibility of drugs and treatments across the countries, which can further propel growth in the coming years.

Overactive Bladder Treatment Market Report Highlights:

  • Mirabegron drug dominated the market in 2023 with a which can be attributed to the high adoption and prescription rate of Mirabegron for treating OAB
  • Among disease-type segments, the idiopathic overactive bladder segment was the largest revenue contributor for the industry in 2023 due to its high prevalence rate
  • In the distribution channel segment, the retail pharmacies dominated the market. The higher revenue growth is attributed to the presence of established retail pharmacies offering OAB drugs and its better patient compatibility
  • North America dominated the market for overactive bladder treatment in 2023 owing to the presence of key players such as Pfizer, Inc., AbbVie, Inc., and Viatris, Inc. across the region
Show more
Product Code: GVR-4-68040-168-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Segment Definitions
    • 1.1.1. Product Segment
    • 1.1.2. Strength Segment
    • 1.1.3. Distribution Channel Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. Gvr's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations
  • 1.12. Research Assumptions

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of target diseases
      • 3.2.1.2. Rising R&D investments for introducing new treatments
      • 3.2.1.3. Growing awareness about the condition
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Adverse effects associated with medications and treatment.
      • 3.2.2.2. Increasing product recalls
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Overactive Bladder Treatment Market: Type Movement Analysis
  • 4.2. Anticholinergics
    • 4.2.1. Anticholinergics Market, 2018 - 2030 (USD Million)
  • 4.3. Mirabegron
    • 4.3.1. Mirabegron Market, 2018 - 2030 (USD Million)
  • 4.4. Botox
    • 4.4.1. Botox Market, 2018 - 2030 (USD Million)
  • 4.5. Neuromodulation
    • 4.5.1. Neuromodulation Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Other Types Market, 2018 - 2030 (USD Million)

Chapter 5. Disease Type Business Analysis

  • 5.1. Overactive Bladder Treatment Market: Disease Type Movement Analysis
  • 5.2. Idiopathic Overactive Bladder
    • 5.2.1. Idiopathic Overactive Bladder Market, 2018 - 2030 (USD Million)
  • 5.3. Neurogenic Overactive Bladder
    • 5.3.1. Neurogenic Overactive Bladder Market, 2018 - 2030 (USD Million)

Chapter 6. Distribution Channel Business Analysis

  • 6.1. Overactive Bladder Treatment Market: Distribution Channel Movement Analysis
  • 6.2. Hospital Pharmacies
    • 6.2.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacies
    • 6.3.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Overactive Bladder Treatment Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. U.S. Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Canada Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. UK Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Germany Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. France Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Italy Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Spain Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Denmark Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Sweden Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Norway Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Japan Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. China Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. India Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Australia Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Thailand Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. South Korea Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Brazil Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Mexico Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. Argentina Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. South Africa Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Saudi Arabia Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. UAE Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Kuwait Overactive Bladder Treatment Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Pfizer, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. AbbVie Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Astellas Pharma Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Medtronic
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Sumitomo Pharma America, Inc.( Urovant Sciences.)
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Viatris Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Teva Pharmaceutical Industries Ltd.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Hisamitsu Pharmaceutical Co., Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Macleods Pharmaceuticals Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Endo International plc
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-168-0

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 4 Global Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 5 Global Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 6 Global Overactive Bladder Treatment Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 7 North America Overactive Bladder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 8 North America Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 9 North America Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 10 North America Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 12 U.S. Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 14 Canada Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 15 Canada Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 16 Canada Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 17 Europe Overactive Bladder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 18 Europe Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 19 Europe Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 20 Europe Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 21 UK Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 22 UK Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 23 UK Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 24 Germany Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 25 Germany Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 26 Germany Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 27 France Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 28 France Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 29 France Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 30 Spain Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 31 Spain Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 32 Spain Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 33 Italy Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 34 Italy Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 35 Italy Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 36 Denmark Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 37 Denmark Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 38 Denmark Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 39 Norway Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 40 Norway Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 41 Norway Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 42 Sweden Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 43 Sweden Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 44 Sweden Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 45 Asia Pacific Overactive Bladder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 49 China Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 50 China Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 51 China Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 52 Japan Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 53 Japan Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 54 Japan Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 55 India Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 56 India Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 57 India Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 58 South Korea Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 60 South Korea Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 61 Australia Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 62 Australia Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 63 Australia Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 64 Thailand Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 65 Thailand Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 66 Thailand Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 67 Latin America Overactive Bladder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 69 Latin America Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 70 Latin America Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 71 Brazil Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 72 Brazil Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 73 Brazil Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 74 Mexico Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 75 Mexico Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 76 Mexico Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 77 Argentina Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million),
  • TABLE 78 Argentina Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 79 Argentina Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 80 MEA Overactive Bladder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 81 MEA Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 82 MEA Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 83 MEA Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 84 South Africa Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 85 South Africa Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 86 South Africa Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 87 UAE Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 88 UAE Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 89 UAE Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 90 Saudi Arabia Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million),
  • TABLE 91 Saudi Arabia Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 92 Saudi Arabia Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • TABLE 93 Kuwait Overactive Bladder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 94 Kuwait Overactive Bladder Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
  • TABLE 95 Kuwait Overactive Bladder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Overactive bladder treatment market segmentation
  • Fig. 8 Market snapshot, 2023
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global overactive bladder treatment market: Type outlook and key takeaways
  • Fig. 15 Global overactive bladder treatment market: Type movement analysis
  • Fig. 16 Global overactive bladder treatment market, for anticholinergics, 2018 - 2030 (USD Million)
  • Fig. 17 Global overactive bladder treatment market, for mirabegron, 2018 - 2030 (USD Million)
  • Fig. 18 Global overactive bladder treatment market, for Botox, 2018 - 2030 (USD Million)
  • Fig. 19 Global overactive bladder treatment market, for neuromodulation, 2018 - 2030 (USD Million)
  • Fig. 20 Global overactive bladder treatment market, for other types, 2018 - 2030 (USD Million)
  • Fig. 21 Global overactive bladder treatment market: Disease type outlook and key takeaways
  • Fig. 22 Global overactive bladder treatment market: Disease type movement analysis
  • Fig. 23 Global overactive bladder treatment market, for idiopathic overactive bladder, 2018 - 2030 (USD Million)
  • Fig. 24 Global overactive bladder treatment market, for neurogenic overactive bladder, 2018 - 2030 (USD Million)
  • Fig. 25 Global overactive bladder treatment market: Distribution channel outlook and key takeaways
  • Fig. 26 Global overactive bladder treatment market: Distribution channel movement analysis
  • Fig. 27 Global overactive bladder treatment market, for hospital pharmacy, 2018 - 2030 (USD Million)
  • Fig. 28 Global overactive bladder treatment market, for retail pharmacy, 2018 - 2030 (USD Million)
  • Fig. 29 Global overactive bladder treatment market, for others, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional outlook, 2022 & 2030
  • Fig. 32 Global overactive bladder treatment market: Region movement analysis
  • Fig. 33 North America overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 U.K overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 France overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 47 China overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 India overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 UAE overactive bladder treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait overactive bladder treatment market, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!